Singular Genomics Systems Stock Market Value
| OMIC Stock | USD 21.37 0.05 0.23% |
| Symbol | Singular |
Singular Genomics Systems Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Singular Genomics. If investors know Singular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Singular Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (34.68) | Revenue Per Share 1.107 | Quarterly Revenue Growth 0.459 | Return On Assets (0.24) | Return On Equity (0.52) |
The market value of Singular Genomics Systems is measured differently than its book value, which is the value of Singular that is recorded on the company's balance sheet. Investors also form their own opinion of Singular Genomics' value that differs from its market value or its book value, called intrinsic value, which is Singular Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Singular Genomics' market value can be influenced by many factors that don't directly affect Singular Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Singular Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Singular Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Singular Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Singular Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Singular Genomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Singular Genomics.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Singular Genomics on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Singular Genomics Systems or generate 0.0% return on investment in Singular Genomics over 30 days. Singular Genomics is related to or competes with EUDA Health, Nutex Health, Healthcare Triangle, Mangoceuticals, Common, and Aclarion. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics t... More
Singular Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Singular Genomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Singular Genomics Systems upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.24 | |||
| Information Ratio | 0.154 | |||
| Maximum Drawdown | 129.25 | |||
| Value At Risk | (6.36) | |||
| Potential Upside | 12.24 |
Singular Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Singular Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Singular Genomics' standard deviation. In reality, there are many statistical measures that can use Singular Genomics historical prices to predict the future Singular Genomics' volatility.| Risk Adjusted Performance | 0.1329 | |||
| Jensen Alpha | 2.71 | |||
| Total Risk Alpha | 0.0981 | |||
| Sortino Ratio | 0.6322 | |||
| Treynor Ratio | 3.79 |
Singular Genomics Systems Backtested Returns
Singular Genomics is very risky given 3 months investment horizon. Singular Genomics Systems owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.16, which indicates the firm had a 0.16% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.86% are justified by taking the suggested risk. Use Singular Genomics Systems Risk Adjusted Performance of 0.1329, coefficient of variation of 619.44, and Semi Deviation of 2.98 to evaluate company specific risk that cannot be diversified away. Singular Genomics holds a performance score of 12 on a scale of zero to a hundred. The entity has a beta of 0.74, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Singular Genomics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Singular Genomics is expected to be smaller as well. Use Singular Genomics Systems semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to analyze future returns on Singular Genomics Systems.
Auto-correlation | -0.85 |
Excellent reverse predictability
Singular Genomics Systems has excellent reverse predictability. Overlapping area represents the amount of predictability between Singular Genomics time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Singular Genomics Systems price movement. The serial correlation of -0.85 indicates that around 85.0% of current Singular Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.85 | |
| Spearman Rank Test | -0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 0.33 |
Singular Genomics Systems lagged returns against current returns
Autocorrelation, which is Singular Genomics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Singular Genomics' stock expected returns. We can calculate the autocorrelation of Singular Genomics returns to help us make a trade decision. For example, suppose you find that Singular Genomics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Singular Genomics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Singular Genomics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Singular Genomics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Singular Genomics stock over time.
Current vs Lagged Prices |
| Timeline |
Singular Genomics Lagged Returns
When evaluating Singular Genomics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Singular Genomics stock have on its future price. Singular Genomics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Singular Genomics autocorrelation shows the relationship between Singular Genomics stock current value and its past values and can show if there is a momentum factor associated with investing in Singular Genomics Systems.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Singular Genomics Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Singular Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Singular Genomics Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Singular Genomics Systems Stock:Check out Singular Genomics Correlation, Singular Genomics Volatility and Singular Genomics Alpha and Beta module to complement your research on Singular Genomics. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Singular Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.